Stay updated on Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:47:32.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding lapse operating-status notice and the previous Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T12:11:27.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and operating status has been added, with guidance to opm.gov for updates. The page now shows a new revision tag (v3.4.1) replacing the previous (v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:36:22.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and new metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0); core study content remains unchanged.
    Difference
    0.2%
    Check dated 2026-01-28T06:28:16.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page revision update shows Revision: v3.3.4, replacing the previous v3.3.3; no study details or eligibility information were changed.
    Difference
    0.1%
    Check dated 2026-01-14T03:38:40.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2, with no impact to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:15:12.000Z thumbnail image

Stay in the know with updates to Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.